Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

AMPH

Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AMPH
일자시간출처헤드라인심볼기업
2024/05/0905:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0906:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0906:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0906:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0708:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0707:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0707:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0510:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0206:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/03/0106:53Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/02/2906:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/02/1007:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/02/0309:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/02/0206:03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/2401:53Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/1206:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/1108:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/1106:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/1006:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/0906:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/0409:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2024/01/0306:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/12/0608:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/12/0510:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/12/0206:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/11/1802:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/11/1606:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/11/1402:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/11/0906:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
2023/11/0906:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AMPHAmphastar Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:AMPH